Safety and Efficacy of Prulifloxacin vs Placebo in Treatment of Acute Gastroenteritis in Adult Travelers
Clinical trial NCT00448422 · COMPLETED
Trial details
- NCT number
- NCT00448422
- Sponsor
- Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2008-08-01
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.